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liver Transplantation for 
Inborn Errors of Metabolism* 
T. E. STARZL, C. W. PUTNAM and 
L. KOEP 
In this report, we propose to show how liver transplantation has been used to 
treat a number of inborn errors of metabolism. Such procedures have not only 
been of considerable benefit to the patients, but also have shed light upon some 
basic pathophysiological mechanisms of the metabolic defects involved. In the 
future, additional information about other hepatic-based inborn errors should 
emerge with this approach .. 
The broad topic of orthotopic liver transplantation, or liver replacement. has 
been discussed by Professor Roy Caine of Cambridge elsewhere in this 
volume. The scope of this article will therefore be limited to the application of 
this procedure to the treatment ofmetabolic disorders. 
METABOLIC SPECIFICITY OF THE DONOR LIVER 
-
The potential curability by liver transplantation of hepatic-based inborn errors 
of metabolism was established in the mid and late 1960s by observations 
involving analysis of serum haptoglobin phenotypes of recipients before and 
after transplantation. Earlier, Smithies had demonstrated that three phenotypes 
of haptoglobin could be identified on the basis of their different electrophoretic 
mobilities in starch geP. In those cases in which th~ donor and recipient 
phenotypes differed, the recipient always adopted the donor type after 
transplantation2, as in Figure 1. This conversion was permanent. Moreover, 
similar substitutions of donor for recipient phenotype were also seen when 
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Figure 1 The effect of orthotopic liver transplantation on serum haptoglobin phenotype. 
Preoperatively. the recipient was classified as Smithies type 2-1 by starch gel electrophoresis; 
the liver donor was type 2-2. Postoperatively, only the donor type was detectable in the 
recipient's serum (by permission of W. B. Saunders Co. 19692) 
group specific component (another alpha globulin) an,f the C'3 component of 
complement were analyzed 2• Thus, the case was made that the liver retained its 
metabolic specificity after its transplantation into anew environment. 
, 
, 
ALPHA,-ANTITRYPSIN DEFICIENCY 
From these observations of haptoglobin and other serum proteins, the cure 
of alphaJ-antitrypsin deficiency by liver - transplantation could be 
predicted. 
AlphaJ-antitrypsin, the chief component of the alphacglobulin fraction 
of human plasma, is an inhibitor of proteolytic enzymes such as trypsin, 
chymotrypsin and collagenase. As with haptoglobin and group-specific 
component, there are identifiable phenotypes of which at least 17 have been 
"described so far3, using discontinuous acid starch gel electrophoresis. In 
-alphacantitrypsin deficiency, the presence of the abnormal phenotype pjZz (the 
most common phenotype is PiMM ) is accompanied by alpha I-antitrypsin 
concentrations approximately 10% of normal. Twenty to 30% of children with 
this phenotype will develop infantile cirrhosis4 ; the condition also predisposes 
in adults to cirrhosis or pulmonary emphysema of early onset and, rarely, both 
hepatic and pulmonary disease, either in childhood or adult life. The 
homozygous PizZ phenotype is encountered in about one in 2500 live births. 
Iii. November 1973, we treated by liver transplantation a 16-year-old girl 
with cirrhosis caused by homozygous alphacantitrypsin deficiency5. Chronic 
rejection eventually caused failure of the graft and she was retransplanted 2l 
years after the first operation. She died 5 weeks later, after a total survival of 2 
years, 4 months. 
Multiple donor and recipient serum samples were examined by Drs Allan G. 
Redeker and Robert L. Peters of Los Angeles (Table 1). Preoperatively, the 
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Table I Alphat,antitrypsin phenotype and concentration before and after transplantation 
A lpha"antitl}psin Pretransplant First donor Post,transplant Second donor After 18 mo. 26 mo. retransplant 
Phenotype ZZ MM MM MM MZ MZ 
Concentration mgi% SS 264 256 '176 270 
(normal 140-470) 
recipient's serum contained only 55 mg/% of alpha I-antitrypsin; the phenotype 
was Pizzo The donor of the first liver graft had the normal PiMM phenotype. 
After liver replacement, the recipient's aiphal-antitrypsin concentration 
increased to normal levels and had the donor's PiMM phenotypeS, By 
coincidence, the second homograft was from a donor with the heterozygous 
mi~Dw phenotype, (In heterozygotes, the alpha1-antitrypsin concentration is 
about 60% of normal but there does not appear to be any predisposition to 
liver disease.) After the second transplant, the recipient again adopted the 
donor's phenotype, this time PiMzs. . 
Histological examination of both hepatic homografts was performed by 
Professor K. A. Porter of London and Dr Robert L. Peters of Los Angeles. 
With the periodic acid Schiff and the peroxidase-labeled antibody methods, 
both of which are specific techniques for identifying the telltale alpha)-
antitrypsin granules in the liver, no evidence of glycoprotein deposition could 
be foundS. 
From this experiences, and from observations reported by Sharp and 
his associates4 of two children with alpha I-antitrypsin deficiency who 
survived for about 1 month after liver transplantation at the University of 
Minnesota, it has been established that the liver is the sole source of the 
deficient alphaglobulin. Furthermore, the provision of a new liver not having 
the abnorIl1a1 PizZ phenotype is curative of the hepatic disease and, 
presumably, is also protective of other organs such as the lung which are 
adversely affecteaby antitrypsin deficiency. 
WILSON'S DISEASE 
Much the same conclusion can be drawn from our observations in two pa~ients 
treated with liver replacement for Wilson's disease. \In this inborn error of 
metabolism, there is progressive accumulation of copper in the body. The 
characteristic Kayser-Fleischer rings, which represent discoloration of the 
corneas with copper, may be detected by slit-lamp examination. More 
importantly, deposition of the metal in the liver and the brain may cause 
subsequent degenerative changes. The biochemical abnormalities associated 
with the disease include elevation of the albumin-bound serum copper 
concentration, increased urinary excretion of cQPper, very low levels of the 
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copper-containing serum protein ceruloplasmin, and a low total serum copper 
concentration. 
We have transplanted two children with hepatic cirrhosis caused by Wilson's 
disease'. The first was an Il-year-old boy, who survived 6 years after liver 
replacement; the cause of death was a partial biliary obstruction unrelieved by 
late reoperation. Postoperatively, repeated liver biopsies showed that there was 
no tendency to accumulate copper within the new organ. A prolonged 
cupriuresis after operation substantially reduced the total body copper content. 
Moreover, copper excretion after penicillamine showed a normal response. 
This patient was studied in collaboration with Stemlieb and Scheinberg of 
New York. Certain features of the case were atypical - the serum 
ceruloplasmin was in the low normal range and there were no Kayser-
Fleischer rings - but the very high copper concentration in the native liver left 
little doubt about the diagnosis. Nonetheless, the potential usefulness of the 
metabolic observations in this case was diminished by the atypical 
biochemical findings. 
Such reservations did not apply to the second recipient, who had all the 
classical features (including Kayser-Fleischer rings) of Wilson's disease'. He 
was first diagnosed at the age of 11 years. Within 3 years he had signs of 
progressive deterioration of hepatic functiop, including ascites. However, the 
recommendation for transplantation was based more on the seriousness of his 
progressive neurological impairment than because of liver failure. The 
neurological symptoms included dystonia, dysarthria and choreoathetosis. 
Symptomatically and biochemically, he was unresponsive to D-penicillamine 
and triethyltetramine dihydrochloride. 
In March 1971, orthotopic hepatic transplantation was performed. 
Postoperatively, immunosuppression was with cyclophosphamide (for which 
azathioprine was later substituted), prednisone and a 3-month course of 
heterologous antilymphocyte globulin. At present, his liver function is normal 
(Figure 2), 51 years post-transplantation. 
His' own liver removed at the time of transplantation had a markedly~D 
increased copper content. However, biopsies of the homograft at 1, 11 and 31 
years postoperatively showed tissue copper levels of 30, 45 and 27 mg/g wet 
weight, respectively - values only slightly above normal. Histologically, the 
biopsies appeared normal. The Kayser-Fleischer rings gradually reabsorbed 
and had disappeared entirely by the third postoperative year. The biochemical 
abnormalities similarly were gradually corrected (Figure 2). Most importantly, 
the neurological abnormalities have completely resolved. 
NIEMANN-PI,CK DISEASE 
The list of inborn errors of metabolism effectively treated with liver 
transplantation will undoubtedly lengthen. Daloze and Corman and their 
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Figure 2 The postoperative course and biochemical findings for the frrst 17 months after 
liver transplantation in our second patient treated for Wilson's disease. After liver replacement, 
the serum ceruloplasmin, which was virtually absent preoperatively, rapidly increased to normal; 
the total serum copper showed a similar trend. Urinary copper excretion, which was elevated 
preoperatively, eventually declined. Moreover. the response to penicillamine was normal (by 
pennission of Transplant. PrOc. (J 973). S, 829') 
associates8 have treated a 2-year-old child with Niemann-Pick disease, in 
whom the liver had been severely damaged by deposits of sphingomyelin 
within it. After transplantation;- the homograft showed no tendency to 
accumulate sphingomyelin; sph-ingomyelinase, the deficient enzyme in this 
disorder, was found in nonnal concentrations in the peripheral blood, urine, 
cerebrospinal fluid and the graft itself. Unfortunately, the severe neurological 
impairment already present preoperatively did not improve and in fact 
contributed to the death of the child from aspergillus pneumonia almost 2 
years after transplantation. At autopsy, sphingomyelinase activity was also 
detectable in the cerebral tissue. 
TYROSINEMIA \ 
Finally, we recently perfonned liver replacement in a lO-year-old child with 
tyrosinemia. A multifocal hepatoma had also developed within the severely 
cirrhotic liver. During the first 2 postoperative months, the serum and urine 
tyrosine concentrations rapidly became normal. Urinary excretion of p-
hydroxyphenylpyruvic acid products also declined to nearly normal levels. 
These fmdings suggest that this inborn error is c0,rrectable by transplantation. 
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Detailed metabolic studies now in progress should shed further light upon the 
pathophysiological mechanisms of this disorder. 
INBORN ERRORS OF METABOLISM AND THE TOTAL 
TRANSPLANT EXPERI ENCE 
It is worthwhile noting that these recipients of liver grafts for inborn errors 
constitute only a s~agl proportion of our experience with liver transplantation 
(Table 2). Of the first 114 patients, 63 were in the pediatric age range. Out of 
Table 2 Orthotopic liver transplant 
experience at tbe University of Colorado 
Recipients 114 
Adult 51 
Pediatric 63 
Biliary atresia S 2 
Other liver diseases 7 
Metabolic diseases 4 
63 children 52 were transplanted for biliary atresia; only four were treated for 
metabolic diseases. Two of the four have lived more than 5 years after 
operation and three have lived more than 2 years. Two are still alive, one after 
2 months and the other after nearly 5! years. 
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